Boosters and vaccinating children mean we’re relying on two pharmaceutical companies to supply Australia’s COVID vaccines. That needs to change.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Vaccine supply chains
Menampilkan semua artikel
We’re reliant on overseas supply - and the many moving parts of delivery. Each of those parts require staff on the ground – and many workers in this system are likely being affected by Omicron.
With enough vaccine supplies coming online from October, the government has no excuse not to have all arrangements in place for an efficient vaccination program. Here’s what needs to change.
There are tangible things we can do now to help people understand the benefits and possible risks of COVID-19 vaccination.
The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
Supply chain issues can be addressed – but the issues with the AstraZeneca vaccine are political, too.
Getting a vaccine is proving difficult for many older people now, but the mad rush for the vaccine won’t last long. Many people don’t want to get one at all, and that will impede herd immunity.
The vaccines’ cold storage requirements and shipment rules put small, rural communities at a disadvantage, but that’s only part of a long-running challenge.
Kontributor teratas
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice, The University of Melbourne
-
Senior Research Fellow, University of Sydney
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Assistant Professor of Political Science, Oklahoma State University
-
Research Fellow, University of Sydney
-
Henry Baldwin Professorial Research Fellow in Health System Sustainability, University of Tasmania
-
Assistant Professor Supply Chain Management & Social Responsibility, Hanken School of Economics
-
Senior Associate, Grattan Institute
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Professor of Technology Management and Circular Economy, University of Bradford
-
Professor of Rural Nursing, Binghamton University, State University of New York
-
Clinical Assistant Professor, Pharmacy Practice, Binghamton University, State University of New York
-
Dean of the Faculty of Management, Law and Social Sciences and Professor of Circular Economy, University of Bradford
